The Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) is launching a new innovative research program Biomedical Artificial Intelligence (AI) – BioAI Dresden. This new research division will combine innovative AI methods with knowledge from biochemistry and physics across the entire spectrum of biology, with the aim of making a decisive contribution to a new scientific understanding of our health.
We are issuing a call for expressions of interest and nominations for a director to lead this new field of BioAI Dresden. The successful candidate will be responsible for heading innovative research in areas, that might include, but are not limited to developing AI methods that meet the complexity of living systems, high-dimensional machine learning for biology, AI-driven laboratory automation, and physics- and biology-inspired machine learning. The director will be expected to have a strong research profile in these or related areas and will be supported by a collaboration with the Boehringer-Ingelheim Foundation and the TUD Dresden University of Technology.
Expressions of interest and nominations can be submitted to the MPI-CBG by August 15th.
Please follow the link here for further information.
About Us & the Environment
- About MPI-CBG: https://www.mpi-cbg.de/about-us/
- About the Max Planck Society: https://www.mpg.de/en
- Our Research Areas and Groups: https://www.mpi-cbg.de/research/our-research/research-areas#c5002
Collaborative & Institutional Links
- Center for Systems Biology Dresden (CSBD): https://www.csbdresden.de
- Boehringer Ingelheim Foundation: https://www.boehringer-ingelheim-stiftung.de/en.html
- TUD Dresden University of Technology: https://tu-dresden.de
- DRESDEN-concept (Campus Alliance): https://dresden-concept.de/en/
Working & Living in Dresden
- Working at MPI-CBG: https://www.mpi-cbg.de/join-us/why-mpi-cbg
- Living in Dresden: https://www.mpi-cbg.de/research/scientific-cores-support/supporting-services/international-office